What Skinive does

Skinive B.V., founded in 2020 and headquartered in Amsterdam, Netherlands, is a CE-Marked AI dermatology software company that analyzes smartphone-captured skin images to detect and classify more than 55 conditions including skin cancer, HPV, herpes, acne, eczema, psoriasis, and fungal infections. The platform combines a consumer-facing Skinive app with a clinical decision-support Skinive MD app for primary-care practitioners, both built on a computer vision and deep learning pipeline featuring AI-based real-time camera guidance and 3D full-body mole-mapping. Underlying model performance is reinforced by a continuously growing proprietary dataset of 6,426,245 skin checks, supporting a 14.79% risk identification rate as of June 2026.

The company monetizes through three distinct channels: a freemium consumer app distributed globally via iOS App Store and Google Play (1M+ users, 4.8 average rating), a subscription-based Skinive MD app targeting clinicians and primary-care providers, and a B2B Dermatology AI API licensed to developers for integration into digital healthcare and beauty applications. The company is privately held with 1-10 employees, has raised approximately $1.14M in disclosed equity funding across rounds led by Rockstart, BergTop VC, the European Network of AI Excellence Centres, and Malta Enterprise, and received non-dilutive support from the EU Horizon 2020 programme (grant agreement No 951847). Leadership is led by CEO Kirill Sokol with Artyom Lyan as Head of AI.

Go-to-market combines product-led growth (self-serve consumer downloads), enterprise field sales (clinician outreach via a dedicated Skinive MD channel), and an API-first developer motion (For Developers segment). Distribution spans eight languages (English, French, Spanish, Russian, German, Japanese, Italian, Dutch) and the product has been showcased at European industry events including the Amsterdam-to-Paris showcase in July 2025. Recent product launches include UV Protection & Monitoring features (May 2026) and a documented 5-year evolution milestone from mole checker to full AI skin scanner (September 2025).

Name

Skinive

Legal name

Skinive B.V.

Website

https://Skinive.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Skinive B.V. is an Amsterdam-based AI dermatology company that offers CE-Marked mobile apps and a developer API for detecting 55+ skin conditions from smartphone images, serving individual consumers, primary-care clinicians, and digital health developers globally.

Ownership category

akta.pro rank

Product category

AI Dermatology Software

NAICS

Hair, Nail, and Skin Care Services (81211)

akta.pro primary industry

Dermatology Telemedicine Platforms (HLALAGAA)

akta.pro secondary industry

Procedural Dermatology (Office-Based Surgery) (HLAKACAG)

Keywords

• AI dermatology software
• Skin condition detection
• Medical imaging AI
• Teledermatology platform
• Computer vision diagnostics

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Consumer App (Freemium): Free app download for patients with core skin scanning features; likely monetized through premium upgrades or in-app purchases for advanced features
2. Skinive MD (Medical Professional App): Dedicated app for clinicians and healthcare providers to improve diagnosis precision and bring efficiency to medical practice
3. Dermatology AI API Licensing: B2B licensing of AI dermatology technology to developers for integration into digital healthcare and beauty applications

Go-to-market motion3 records

Distribution channels4 records

Marketing channels3 records

Core offering

Skinive builds and sells CE-Marked AI-powered dermatology software that analyzes smartphone-captured skin images to detect and classify 55+ skin conditions, including skin cancer, HPV, herpes, acne, eczema, psoriasis, and fungal infections. It delivers this capability through a consumer self-serve Skinive App for at-home skin self-exams, a Skinive MD App for clinicians, and a Dermatology AI API that developers license to embed skin analysis into digital healthcare and beauty applications. The platform uses real-time AI camera guidance and 3D full-body mole-mapping to improve image quality and diagnostic documentation.

Product overview

Skinive offers a multi-product AI-powered dermatology platform consisting of consumer and professional applications plus a developer API. The consumer-facing Skinive App provides at-home skin condition analysis for patients, while the Skinive MD App serves clinicians in primary care settings. Both apps leverage the same underlying AI technology for analyzing 55+ skin conditions. The Dermatological Atlas serves as a reference resource across segments, and the Find a Dermatologist feature connects users to healthcare providers. For technical integrators, the Dermatology AI API enables third-party applications to incorporate Skinive's skin analysis capabilities. All products are CE-Marked medical software.

Differentiator

Problem solved

Functional benefit

Products and services

• Skinive App Consumer mobile application that provides at-home AI-powered pre-diagnosis of skin conditions by analyzing photos of the skin to detect 55+ conditions including acne, eczema, HPV, herpes, fungal infections, and skin cancer. Includes real-time AI camera guidance, risk-level assessment, and UV protection monitoring, and is positioned for individual patients seeking self-monitoring between dermatologist visits.
• Skinive MD App Professional-grade dermatology mobile application for clinicians and medical practitioners in primary-care settings. Provides AI-assisted skin lesion analysis, 3D full-body mole-mapping for documentation, and real-time camera guidance to improve diagnostic precision and practice efficiency.
• Dermatology AI API REST API that allows third-party developers and digital healthcare / beauty app companies to integrate Skinive's CE-Marked AI dermatology analysis into their own applications, providing on-demand detection of 55+ skin conditions.
• Dermatological Atlas (Dermatlas) Reference resource listing skin conditions with visual examples and descriptions, available as a public informational tool for both patients and clinicians.
• Find a Dermatologist directory Directory service hosted on skinive.com that connects Skinive users, particularly those flagged with elevated skin risk, to dermatologists for follow-up appointments.

Quantifiable outcome

• 6,426,245 skin checks performed with 14.79% risk identification rate
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• SkinVision: SkinVision is a well-capitalized AI dermatology app offering smartphone-based skin cancer risk assessment with CE marking and multiple health insurer partnerships across Europe and Australia. It is the most directly comparable consumer + clinician dermatology AI platform to Skinive, competing head-to-head on accuracy claims, regulatory status, and insurer/payer integration.
• Skin Analytics: Skin Analytics is a UK-based AI dermatology company providing DERM (Deep Ensemble for Recognition of Malignancy) for NHS clinical pathways, holding Class III CE-Mark under UKCA. It is a direct peer in the clinician-side, regulatory-grade dermatology AI category that Skinive targets with Skinive MD, but operates at much larger scale with multiple NHS deployments.
• Miiskin: Miiskin is a consumer-facing mole tracking and skin monitoring app that uses AI to help users document and detect changes in skin lesions over time. It is highly comparable to Skinive's consumer app on the mole-mapping, self-exam, and tracking workflow, with similar freemium monetization and a global user base.
• FotoFinder Systems: FotoFinder is a German medical device company specializing in AI-powered dermoscopy, total body mole mapping, and skin cancer diagnostics used by dermatologists worldwide. It is comparable to Skinive as an AI dermatology platform, but targets clinic-based procedural workflows rather than smartphone-based consumer pre-screening.
• MetaOptima Technology: MetaOptima builds the DermEngine teledermatology and AI skin imaging platform used by clinicians and partners across North America, Europe, and APAC. It is comparable to Skinive as a dermatology AI platform serving both clinicians and enterprise partners, with similar APIs and integrations into clinical workflows.

Emerging players

• DermaSensor: DermaSensor is an FDA Breakthrough-designated AI-enabled handheld spectroscopy device for primary care physicians to evaluate skin lesions for cancer risk. It targets the same primary-care decision support use case as Skinive MD but uses a dedicated hardware device rather than smartphone-based imaging.
• Skinopathy: Skinopathy is a Canadian AI dermatology company providing image-based skin analysis tools to patients, clinicians, and enterprise partners including pharmacy and telehealth channels. It is comparable to Skinive as an early-stage multi-segment dermatology AI platform with both consumer and API/B2B distribution strategies.
• SkinScreener: SkinScreener is an Austrian CE-marked AI-based smartphone app that classifies skin lesions as low, medium, or high risk, targeting both consumers and clinicians across Europe. It is highly comparable to Skinive in scope, regulatory posture, and target use case, though with narrower condition coverage and smaller user base.

Broad incumbents

• Google DermAssist (Google Health): Google's DermAssist is a web-based AI dermatology assistant that lets users photograph skin, hair, or nail conditions and receive condition matches, integrated across Google Search and Pixel devices. It is a broad incumbent competitor that can leverage Google's distribution to deliver AI dermatology at near-zero marginal cost, posing a strategic threat to independent apps like Skinive.
• L'Oréal Beauty Genius / Skin Diagnostic: L'Oréal has integrated AI skin diagnostic and recommendation tools (Beauty Genius, Effaclar Spotscan) into its consumer beauty apps and partnered with dermatology AI providers. As a beauty incumbent moving into AI skin analysis, L'Oréal is a relevant comparable for Skinive's API/beauty app licensing GTM, and a potential customer rather than direct competitor in some scenarios.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks3 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/skiniver

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Skinive